Viewing Study NCT00846768


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-05-16 @ 6:30 PM
Study NCT ID: NCT00846768
Status: COMPLETED
Last Update Posted: 2014-07-01
First Post: 2009-02-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords: